<?xml version="1.0" encoding="UTF-8"?>
<p>A 2004 study by El-Feraly isolated, characterized and synthesized dihydro-resveratrol (3,5,4′-trihydroxybibenzyl), a metabolite derivative of the antioxidant, resveratrol, a dihydrostilbenoid from 
 <italic>Cannabis sativa</italic> (
 <xref ref-type="fig" rid="plants-10-00400-f010">Figure 10</xref> above) [
 <xref rid="B74-plants-10-00400" ref-type="bibr">74</xref>]. A 2019 study by Giménez-Bastida and colleagues reported that dihydro-resveratrol and other metabolite derivatives of resveratrol induced senescence in breast cancer cells [
 <xref rid="B75-plants-10-00400" ref-type="bibr">75</xref>]. Studies on the antioxidant activity of dihydro-resveratrol are limited. A 2016 study by Tsang and colleagues report that dihydro-resveratrol demonstrated the ability to attenuate pancreatic oxidative damage and could possibly have therapeutic potential in the management of acute pancreatitis [
 <xref rid="B3-plants-10-00400" ref-type="bibr">3</xref>].
</p>
